NEW YORK STOCK EXCHANGE, INC. · MRK
+0.52% · +$0.7600 · Vol Not reported
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Merck & Co Inc

Merck & Co Inc

Pharmaceuticals
$145.95
Card
Relationship Map

Follow $MRK

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $MRK by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
MRK
Merck & Co Inc
Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

74/ 100
Veridion Score
Upper range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
AI Analysis
Sovereign

Why is MRK moving today?

Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About Merck & Co Inc
PHARMACEUTICAL PREPARATIONS
Listed since
1949
Employees
75K
Country
US

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$146.96
Day high
$147.79
Day low
$145.61
Previous close
$145.19
52W high
$156.45
-6.71% from high
52W low
$82.49
86% of range
Market cap
$360.1B
P/E
113.48×
EPS
$1.25
Beta
-0.20
Shares out
2.5B
Avg volume
9.7M
VWAP
$145.19
Last session
Price history computed in-house
1W
+0.24%
1M
-0.63%
3M
+17.32%
1Y
+72.13%
YTD
+38.66%
SMA 50 $145.12 · above
SMA 200 $124.87 · above
52W position 86%

MRK overview

Receipt-backed holder profiles
SEC industry peers

MRK peers

Public disclosures

Congress activity in MRK

58 filers · 90 buys · 90 sells (1 labeled S (partial)) · Jan 23, 2014 to Sep 24, 2026 · House 163 / Senate 17

All available history · Latest 5 of 180 lines · Read Oct 18, 2026, 12:08 PM UTC

Federal contracts

MRK contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MRK in this window.
Lobbying spend

MRK lobbying filings, year to date.

Registered lobbying filings matched to Merck & Co Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MRK in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for MRK.
Veridion by email

Disclosure findings, methodology notes, and product updates when we have them. No fixed schedule yet. No advertising list resale.